Primary colorectal lymphomas

Background/Aim. Colorectal lymphoma is a rare tumor representing 1.4% of human lymphomas, 10-20% of gastrointestinal lymphomas, namely 0.2-0.6% of all malignancies in the colon. The aim of this study was to review clinical characteristics of primary colorectal lymphoma and overall survival. Methods....

Full description

Saved in:
Bibliographic Details
Main Authors: Stanojević Goran, Stojanović Miroslav, Jovanović Milan, Stojanović Miodrag, Jeremić Miroslav, Branković Branko, Ignjatović Nebojša, Katić Vuka V.
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2009-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500904295S.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395291572142080
author Stanojević Goran
Stojanović Miroslav
Jovanović Milan
Stojanović Miodrag
Jeremić Miroslav
Branković Branko
Ignjatović Nebojša
Katić Vuka V.
author_facet Stanojević Goran
Stojanović Miroslav
Jovanović Milan
Stojanović Miodrag
Jeremić Miroslav
Branković Branko
Ignjatović Nebojša
Katić Vuka V.
author_sort Stanojević Goran
collection DOAJ
description Background/Aim. Colorectal lymphoma is a rare tumor representing 1.4% of human lymphomas, 10-20% of gastrointestinal lymphomas, namely 0.2-0.6% of all malignancies in the colon. The aim of this study was to review clinical characteristics of primary colorectal lymphoma and overall survival. Methods. A detailed analysis of 16 surgically treated patients included patients age, symptoms and signs, tumor site, type of surgery, histopathologic findings, diagnosis of the disease, disease stage, type of surgery related to the degree of emergency (elective or urgent), applied adjuvant therapy, patient follow-up and treatment outcomes. Survival was expressed by the Kaplan-Meier curve, while the difference in survival among the two groups by the Log-rank test. Results. The all patients were on an average followed-up for a median of 29 months (range 2-60 months), while those with chemotherapy 48 months (range 4-60 months). An overall mean survival time was 38.65 months. Conclusion. Primary colorectal lymphoma is a rare malignant tumor of the large bowel. Therapy usually involves resection of the affected colon or rectum and regional lymphovascular structures, followed by adjuvant therapy. Survival period is short and, therefore, timely diagnosis is crucial in early disease stages when the probability of cure is high.
format Article
id doaj-art-ad9737631b3442efa3abda20a0501b95
institution Kabale University
issn 0042-8450
language English
publishDate 2009-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-ad9737631b3442efa3abda20a0501b952025-08-20T03:39:40ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502009-01-0166429530110.2298/VSP0904295SPrimary colorectal lymphomasStanojević GoranStojanović MiroslavJovanović MilanStojanović MiodragJeremić MiroslavBranković BrankoIgnjatović NebojšaKatić Vuka V.Background/Aim. Colorectal lymphoma is a rare tumor representing 1.4% of human lymphomas, 10-20% of gastrointestinal lymphomas, namely 0.2-0.6% of all malignancies in the colon. The aim of this study was to review clinical characteristics of primary colorectal lymphoma and overall survival. Methods. A detailed analysis of 16 surgically treated patients included patients age, symptoms and signs, tumor site, type of surgery, histopathologic findings, diagnosis of the disease, disease stage, type of surgery related to the degree of emergency (elective or urgent), applied adjuvant therapy, patient follow-up and treatment outcomes. Survival was expressed by the Kaplan-Meier curve, while the difference in survival among the two groups by the Log-rank test. Results. The all patients were on an average followed-up for a median of 29 months (range 2-60 months), while those with chemotherapy 48 months (range 4-60 months). An overall mean survival time was 38.65 months. Conclusion. Primary colorectal lymphoma is a rare malignant tumor of the large bowel. Therapy usually involves resection of the affected colon or rectum and regional lymphovascular structures, followed by adjuvant therapy. Survival period is short and, therefore, timely diagnosis is crucial in early disease stages when the probability of cure is high.http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500904295S.pdfcolonic neoplasmscolorectal neoplasmslymphomasdiagnosisneoplasm stagingtherapeuticsdigestive system surgical procedurestreatment outcomesurvival analysis
spellingShingle Stanojević Goran
Stojanović Miroslav
Jovanović Milan
Stojanović Miodrag
Jeremić Miroslav
Branković Branko
Ignjatović Nebojša
Katić Vuka V.
Primary colorectal lymphomas
Vojnosanitetski Pregled
colonic neoplasms
colorectal neoplasms
lymphomas
diagnosis
neoplasm staging
therapeutics
digestive system surgical procedures
treatment outcome
survival analysis
title Primary colorectal lymphomas
title_full Primary colorectal lymphomas
title_fullStr Primary colorectal lymphomas
title_full_unstemmed Primary colorectal lymphomas
title_short Primary colorectal lymphomas
title_sort primary colorectal lymphomas
topic colonic neoplasms
colorectal neoplasms
lymphomas
diagnosis
neoplasm staging
therapeutics
digestive system surgical procedures
treatment outcome
survival analysis
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500904295S.pdf
work_keys_str_mv AT stanojevicgoran primarycolorectallymphomas
AT stojanovicmiroslav primarycolorectallymphomas
AT jovanovicmilan primarycolorectallymphomas
AT stojanovicmiodrag primarycolorectallymphomas
AT jeremicmiroslav primarycolorectallymphomas
AT brankovicbranko primarycolorectallymphomas
AT ignjatovicnebojsa primarycolorectallymphomas
AT katicvukav primarycolorectallymphomas